(Total Views: 457)
Posted On: 08/13/2021 9:42:38 AM
Post# of 155038
It depends on who's perspective you're referring to when you say it would be "smart". It sounds like the 13D supporters are searching for holes in Nader's PR statement.
Quote:
Why not release the section of the FDA Guidance which concerns the Clinical Section dealing with the dose justification? Then, shareholders can make their own judgement as to how addressable they are and skeptics will be silenced if the FDA wording is consistent with Nader's PR statement.
(1)
(0)
My comments are just my opinions and should NOT be taken as investment advice.
